Acute leukoencephalopathy and thyroiditis induced by capecitabine.
(2022) Acta Neurologica Belgica — Vol. 122, n° 5, p. 1373-1375 (2022)
Files
s13760-022-01893-5.pdf
Open Access - Adobe PDF
- 579.3 KB
Details
- Authors
Duprez, Thierry 
- Abstract
- (en) TO THE EDITOR, Capecitabine is an oral fuoropyrimidine antimetabolite drug commonly used in several cancer types. Neurological toxicity rarely occurs. We report a case of acute capecitabineinduced leukoencephalopathy and thyroiditis in a breast cancer patient, both rapidly regressing after treatment discontinuation. We discuss hypotheses regarding the physiopathology of these toxic side efects. [...]
- Affiliations
Citations
Mossakowski, M., Jacobs, S., Hanseeuw, B., Duprez, T., & van Marcke de Lummen, C. J. (2022). Acute leukoencephalopathy and thyroiditis induced by capecitabine. Acta Neurologica Belgica, 122(5), 1373-1375. https://doi.org/10.1007/s13760-022-01893-5 (Original work published 2022)